*Trachoma DOI: http://dx.doi.org/10.5772/intechopen.106133*

Journal international d'ophtalmologie International journal of ophthalmology Zeitschrift fur Augenheilkunde. 2000;**214**(4):277-284

[33] Hu VH, Weiss HA, Massae P, Courtright P, Makupa W, Mabey DCW, et al. In vivo confocal microscopy in scarring trachoma. Ophthalmology. 2011;**118**(11):2138-2146

[34] Burton MJ, Ramadhani A, Weiss HA, Hu V, Massae P, Burr SE, et al. Active trachoma is associated with increased conjunctival expression of IL17A and profibrotic cytokines. Infection and Immunity. 2011;**79**(12):4977-4983

[35] Bailey R, Duong T, Carpenter R, Whittle H, Mabey D. The duration of human ocular chlamydia trachomatis infection is age dependent. Epidemiology and Infection. 1999;**123**(3):479-486

[36] Allen HF. Chlamydial eye disease. International Ophthalmology Clinics. 1975;**15**:257-268

[37] Melese M, Alemayehu W, Bejiga A, Adamu Y, Worku A. Modified grading system for upper eyelid trachomatous trichiasis. Ophthalmic Epidemiology. 2003;**10**(2):75-80

[38] Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR. A simple system for the assessment of trachoma and its complications. Bulletin of the World Health Organization. 1987;**65**(4):477-483

[39] Martin DL, Saboya-Diaz MI, Abashawl A, Alemayeh W, Gwyn S, et al. The use of serology for trachoma surveillance: Current status and priorities for future investigation. PLoS Neglected Tropical Diseases. 2020;**14**(9):e0008316

[40] Yang JL, Schachter J, Moncada J, Habte D, Zerihun M, House JI, et al. Comparison of an rRNA-based and

DNA-based nucleic acid amplification test for the detection of chlamydia trachomatis in trachoma. The British Journal of Ophthalmology. 2007;**91**(3):293-295

[41] Michel CEC, Roper KG, Divena MA, Lee HH, Taylor HR. Correlation of clinical trachoma and infection in aboriginal communities. PLoS Neglected Tropical Diseases. 2011;**5**(3):e986

[42] Macleod CK, Bailey RL, Dejene M, Shafi O, Kebede B, Negussu N, et al. Practice of epidemiology estimating the Intracluster correlation coefficient for the clinical sign "trachomatous inflammation-follicular" in populationbased trachoma prevalence surveys: Results from a meta-regression analysis of 261 standardized Preintervention surveys carried out in Ethiopia, Mozambique, and Nigeria. American Journal of Epidemiology World Health Organization. 2020;**189**(1):68-76

[43] Morberg DP, Amza A, Gebresillasie S, Tadesse Z, Yu SN, Stoller NE, et al. Follicle size in trachoma: Assessment of a well-known trachoma grading diagram. The British Journal of Ophthalmology. 2014;**98**(5):706-708

[44] Solomon AW, Engels D, Bailey RL, Blake IM, Brooker S, Chen JX, et al. A diagnostics platform for the integrated mapping, monitoring, and surveillance of neglected tropical diseases: Rationale and target product profiles. PLoS Neglected Tropical Diseases. 2012;**6**(7):e1746

[45] Rashid A, Jakobiec FA. Avoiding the major complication of ophthalmic pathology: Misdiagnosis. A Review of Three Common Diagnostic Challenges. 2014;**29**(August):468-474

[46] Bird M, Dawson CR, Schachter JS, Miao Y, Shama A, Osman A, et al. Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma-endemic areas ? The Journal of Infectious Diseases. 2003;**187**:1669-1673

[47] Aboe A, Joof BM, Kanyi SK, Hydara A, Downs P, Bush S, et al. The Gambia has eliminated trachoma as a public health problem. Challenges and successes. PLoS Neglected Tropical Diseases. 2022;**16**(3):e0010282

[48] Friedrich MJ. Two southeast Asian countries eliminate trachoma. Journal of the American Medical Association. 2017;**318**(19):1857-1857

[49] Hammou J, el Ajaroumi H, Hasbi H, Nakhlaoui A, Hmadna A, el Maaroufi A. In Morocco, the elimination of trachoma as a public health problem becomes a reality. The Lancet Global Health. 2017;**5**(3):e250-e251

[50] Lietman TM, Francisco-San, Catherine Oldenburg CE, San Francisco M, Jeremy Keenan CD. Editorial trachoma: Time to talk eradication. Ophthalmology. 2020;**127**:11-13. DOI: 10.1016/j.ophtha.2019.11.001

[51] Evans JR, Solomon AW, Kumar R, Perez A, et al. Antibiotics for trachoma. Cochrane Database of Systematic Review. 2019;**9**:1-138 [Accessed: July 19, 2022]

[52] World Health Organization G. World Health Organization. Report of the 2nd Global Scientific Meeting on Trachoma. Geneva: WHO; 2003

[53] Alexander NDE, Ph D, Massae PA, Aguirre A, West SK, Bailey RL, et al. Mass treatment with single-dose azithromycin for trachoma. The New England Journal of Medicine. 2004;**351**(19):1962-1971

[54] Bhosai SJ, Bailey RL, Gaynor BD, Lietman TM. Trachoma: An update on prevention, diagnosis, and treatment.

Current Opinion in Ophthalmology. 2012;**23**(4):288-295

[55] Mahmud H, Landskroner E, Amza A, Aragie S, Godwin WW, de Hostos BA, et al. Stopping azithromycin mass drug administration for trachoma: A systematic review. PLoS Neglected Tropical Diseases. 2021;**15**(7):e0009491

[56] Zack R, Mkocha H, Zack E, Munoz B, West SK. Issues in defining and measuring facial cleanliness for national trachoma control programs. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2008;**102**(5):426-431
